Search research articles
Contact Us
Filters
Showing results (1-10 of 10) with videos related to
Page
of 1
Sort By:
Journal of Neuro-Oncology
|
October 8, 2011
Expression of dual angiogenic/neurogenic growth factors in human primary brain tumors
Maud Clemessy, Robert C Janzer, Benoìt Lhermitte, et al.
Seminars in Oncology
|
February 7, 2004
Prognostic factors for low-grade gliomas
Roger Stupp, Robert C Janzer, Monika E Hegi, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
February 28, 2013
Methylation of the hTERT promoter: a novel cancer biomarker for leptomeningeal metastasis detection in cerebrospinal fluids
Stéphanie Bougel, Benoit Lhermitte, Gabrielle Gallagher, et al.
Cancer Investigation
|
June 28, 2008
Heterogeneity of human glioblastoma: glutathione-S-transferase and methylguanine-methyltransferase
Lucienne Juillerat-Jeanneret, Catherine Chapuis Bernasconi, Charlotte Bricod, et al.
Bioorganic & Medicinal Chemistry
|
July 5, 2008
Functionalized pyrrolidine inhibitors of human type II alpha-mannosidases as anti-cancer agents: optimizing the fit to the active site
Hélène Fiaux, Douglas A Kuntz, Daniela Hoffman, et al.
Ophthalmic Genetics
|
April 30, 2011
Chiasmatic infiltration secondary to late malignant transformation of retinoma
Asimina Mataftsi, Leonidas Zografos, Aubin Balmer, et al.
Cancer Research
|
October 30, 2003
Classification of human astrocytic gliomas on the basis of gene expression: a correlated group of genes with angiogenic activity emerges as a strong predictor of subtypes
Sophie Godard, Gad Getz, Mauro Delorenzi, et al.
The New England Journal of Medicine
|
March 11, 2005
MGMT gene silencing and benefit from temozolomide in glioblastoma
Monika E Hegi, Annie-Claire Diserens, Thierry Gorlia, et al.
The New England Journal of Medicine
|
March 11, 2005
Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma
Roger Stupp, Warren P Mason, Martin J van den Bent, et al.
The Lancet. Oncology
|
March 10, 2009
Effects of radiotherapy with concomitant and adjuvant temozolomide versus radiotherapy alone on survival in glioblastoma in a randomised phase III study: 5-year analysis of the EORTC-NCIC trial
Roger Stupp, Monika E Hegi, Warren P Mason, et al.
Page
of 1
Search research articles
Search
Showing results (1-10 of 10) with videos related to
Sort By:
Page
of 1
Journal of Neuro-Oncology
|
October 8, 2011
Expression of dual angiogenic/neurogenic growth factors in human primary brain tumors
Maud Clemessy, Robert C Janzer, Benoìt Lhermitte, et al.
Seminars in Oncology
|
February 7, 2004
Prognostic factors for low-grade gliomas
Roger Stupp, Robert C Janzer, Monika E Hegi, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
February 28, 2013
Methylation of the hTERT promoter: a novel cancer biomarker for leptomeningeal metastasis detection in cerebrospinal fluids
Stéphanie Bougel, Benoit Lhermitte, Gabrielle Gallagher, et al.
Cancer Investigation
|
June 28, 2008
Heterogeneity of human glioblastoma: glutathione-S-transferase and methylguanine-methyltransferase
Lucienne Juillerat-Jeanneret, Catherine Chapuis Bernasconi, Charlotte Bricod, et al.
Bioorganic & Medicinal Chemistry
|
July 5, 2008
Functionalized pyrrolidine inhibitors of human type II alpha-mannosidases as anti-cancer agents: optimizing the fit to the active site
Hélène Fiaux, Douglas A Kuntz, Daniela Hoffman, et al.
Ophthalmic Genetics
|
April 30, 2011
Chiasmatic infiltration secondary to late malignant transformation of retinoma
Asimina Mataftsi, Leonidas Zografos, Aubin Balmer, et al.
Cancer Research
|
October 30, 2003
Classification of human astrocytic gliomas on the basis of gene expression: a correlated group of genes with angiogenic activity emerges as a strong predictor of subtypes
Sophie Godard, Gad Getz, Mauro Delorenzi, et al.
The New England Journal of Medicine
|
March 11, 2005
MGMT gene silencing and benefit from temozolomide in glioblastoma
Monika E Hegi, Annie-Claire Diserens, Thierry Gorlia, et al.
The New England Journal of Medicine
|
March 11, 2005
Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma
Roger Stupp, Warren P Mason, Martin J van den Bent, et al.
The Lancet. Oncology
|
March 10, 2009
Effects of radiotherapy with concomitant and adjuvant temozolomide versus radiotherapy alone on survival in glioblastoma in a randomised phase III study: 5-year analysis of the EORTC-NCIC trial
Roger Stupp, Monika E Hegi, Warren P Mason, et al.
Page
of 1